Man and the Biosphere Programme

May 20, 2020

I-Mab Expands Global Presence with New Hong Kong Office

Sep 12, 2019

I-Mab Biopharma Expands Global Team, Appoints Neil K. Warma As General Manager of I-Mab U.S.

Apr 16, 2019

I-Mab Biopharma and WuXi Biologics Announce Long-term Strategic Manufacturing Partnership for Five Clinical and One Commercial Programs

Jan 22, 2019

I-Mab Biopharma Receives U.S. FDA IND Clearance for Proprietary CD73 Antibody TJD5

Nov 15, 2018

MorphoSys and I-Mab Sign Strategic Partnering Agreement for MorphoSys's Novel Immuno-Oncology Agent MOR210

Nov 02, 2018

I-Mab and Genexine Announce China IND Approval for Innovative Immunotherapy

Sep 19, 2018

I-Mab Wins Frost & Sullivan "2018 Best R&D Innovator Award (Biopharma Category)"

Jul 26, 2018

I-Mab Biopharma and ABL Bio Announce Global Collaboration on Innovative Bispecific Antibodies

Jun 29, 2018

I-Mab Successfully Raised USD 220 Million in Series C Funding

Dec 25, 2017

I-Mab Biopharma Signs Licensing Agreement for HyLeukin With Genexine